PubMed

Latanoprost in port wine stain related paediatric glaucoma.

Ong T, Chia A, Nischal KK.

Br J Ophthalmol. 2003 Sep;87(9):1091-3.PMID: 12928274 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of additive preoperative latanoprost treatment on the outcome of filtration surgery.

Berthold S, Pfeiffer N.

Graefes Arch Clin Exp Ophthalmol. 2006 Aug;244(8):1029-34. Epub 2005 Dec 8.PMID: 16341541 [PubMed - indexed for MEDLINE]Related articles

Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France.

Payet S, Denis P, Berdeaux G, Launois R.

Clin Drug Investig. 2008;28(3):183-98.PMID: 18266403 [PubMed - indexed for MEDLINE]Related articles

[The effectiveness of latanoprost for the treatment of pediatric glaucoma]

Urban B, Bakunowicz-Lazarczyk A, Mrugacz M, Oziebło-Kupczyk M.

Klin Oczna. 2004;106(1-2 Suppl):243-4. Polish. PMID: 15510514 [PubMed - indexed for MEDLINE]Related articles

[Five years retrospective study of latanoprost glaucoma treatment]

Závorková M, Susický P.

Cesk Slov Oftalmol. 2007 Jul;63(4):292-8. Czech. PMID: 17682609 [PubMed - indexed for MEDLINE]Related articles

Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies.

Bayer A, Weiler W, Oeverhaus U, Skrotzki FE, Stewart WC; Xplore Observation Group.

J Ocul Pharmacol Ther. 2004 Dec;20(6):470-8.PMID: 15684807 [PubMed - indexed for MEDLINE]Related articles

Clinical predictors of latanoprost treatment effect.

Bayer A, Henderer JD, Kwak T, Myers J, Fontanarosa J, Spaeth GL.

J Glaucoma. 2005 Aug;14(4):260-3.PMID: 15990603 [PubMed - indexed for MEDLINE]Related articles

Rate of response to latanoprost or timolol in patients with ocular hypertension or glaucoma.

Camras CB, Hedman K; US Latanoprost Study Group.

J Glaucoma. 2003 Dec;12(6):466-9.PMID: 14646680 [PubMed - indexed for MEDLINE]Related articles

Intraocular pressure and safety in glaucoma patients switching to latanoprost/timolol maleate fixed combination from mono- and adjunctive therapies.

Konstas AG, Bányai L, Blask KD, Väth J, Kozobolis VP, Trüb PR, Tsironi S, Maloutas S, Teus MA, Stewart WC.

J Ocul Pharmacol Ther. 2004 Oct;20(5):375-82.PMID: 15650512 [PubMed - indexed for MEDLINE]Related articles

Clinical experience in the treatment of normal tension glaucoma with latanoprost in Germany.

Thelen U, Weiler W, Kirchhoff E, Fuchs HB, Stewart WC.

J Ocul Pharmacol Ther. 2007 Jun;23(3):311-3.PMID: 17593016 [PubMed - indexed for MEDLINE]Related articles

A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.

Maul E, Carrasco FG, Costa VP, Casiraghi JF, Vargas E, Sarmina JS, Mayol R.

Clin Ther. 2007 Sep;29(9):1915-23.PMID: 18035191 [PubMed - indexed for MEDLINE]Related articles

A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma.

Alm A, Schoenfelder J, McDermott J.

Arch Ophthalmol. 2004 Jul;122(7):957-65.PMID: 15249358 [PubMed - indexed for MEDLINE]Related articles

A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.

Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.

Clin Ther. 2006 Mar;28(3):332-9.PMID: 16750448 [PubMed - indexed for MEDLINE]Related articles

Long term effect of latanoprost on intraocular pressure in normal tension glaucoma.

Ang A, Reddy MA, Shepstone L, Broadway DC.

Br J Ophthalmol. 2004 May;88(5):630-4.PMID: 15090413 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.

Parmaksiz S, Yüksel N, Karabas VL, Ozkan B, Demirci G, Caglar Y.

Eur J Ophthalmol. 2006 Jan-Feb;16(1):73-80.PMID: 16496249 [PubMed - indexed for MEDLINE]Related articles

Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.

Law SK, Song BJ, Fang E, Caprioli J.

Ophthalmology. 2005 Dec;112(12):2123-30. Epub 2005 Oct 12.PMID: 16225924 [PubMed - indexed for MEDLINE]Related articles

Persistency and clinical outcomes associated with latanoprost and beta-blocker monotherapy: evidence from a European retrospective cohort study.

Diestelhorst M, Schaefer CP, Beusterien KM, Plante KM, Fain JM, Mozaffari E, Dhawan R.

Eur J Ophthalmol. 2003 Jul;13 Suppl 4:S21-9.PMID: 12948050 [PubMed - indexed for MEDLINE]Related articles

Use of latanoprost in the treatment of glaucoma associated with Sturge-Weber syndrome.

Yang CB, Freedman SF, Myers JS, Buckley EG, Herndon LW, Allingham RR.

Am J Ophthalmol. 1998 Oct;126(4):600-2.PMID: 9780111 [PubMed - indexed for MEDLINE]Related articles

Refill rates and budget impact of glaucoma lipid therapy: a retrospective database analysis.

Walt JG, Wilensky JT, Fiscella R, Chiang TH, Guckian A.

Clin Drug Investig. 2007;27(12):819-25.PMID: 18020539 [PubMed - indexed for MEDLINE]Related articles

The effect of latanoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma.

Oh JY, Park KH.

Korean J Ophthalmol. 2005 Dec;19(4):297-301.PMID: 16491821 [PubMed - indexed for MEDLINE]Related articlesFree article